It has been shown in a cohort of primary melanoma samples from NYU and Vanderbilt that young patients acquire resistance to immunotherapy due to a reduction in FOXP3+ Treg cell population, while old patients (> 66 years) have a small CD8+ T cell population [10]. The gene discussed is FOXP3; the disease is melanoma.